A Soul-Searching Scientist at 35

Like lawyers, doctors and other professionals, scientists spend long years educating and preparing themselves for their careers. But unlike other professionals, scientists seem to do their best work early in life, leaving their later years for administration, consultation and other tasks not necessarily connected to their primary task of solving nature's puzzles. In this excerpt from his new collection of essays, A Modern Day Yankee in a Connecticut Court (Viking Penguin, 1986), Alan Lightman, a

Written byAlan Lightman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In my own case, as with the majority of my colleagues, I concluded that my work was respectable but not brilliant. Very well. Unfortunately, I now have to decide what to do with the rest of my life. My 35-year-old friends who are attorneys and physicians and businessmen are still climbing toward their peaks, perhaps 15 years up the road, and are blissfully uncertain of how high they'll reach. It is an awful thing, at such an age, to fully grasp one's limitations.

Why do scientists peak sooner than most other professionals? No one knows for sure. I suspect it has something to do with the single focus and detachment of the subject. A handiness for visualizing in six dimensions or for abstracting the motion of a pendulum favors a nimble mind but apparently has little to do with anything else. In contrast, the arts and humanities require experience with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies